InsiderTrades.com logo

Wan-Shan Chen Biography and Net Worth

Director of Belite Bio
  • Phone
  • Email
  • Website


Ms. Wan-Shan Chen has served as Belite Bio’s Director since November 2021. Currently, she is a finance executive of Lin BioScience, Inc. (TPEx: 6696), our ultimate controlling shareholder. Ms. Chen received her master’s degree in Accounting from National Taipei University. Ms. Chen is also a certified public accountant in Taiwan.

What is Wan-Shan Chen's net worth?

The estimated net worth of Wan-Shan Chen is at least $1.50 million as of April 9th, 2026. Ms. Chen owns 9,096 shares of Belite Bio stock worth more than $1,504,751 as of April 21st. This net worth evaluation does not reflect any other assets that Ms. Chen may own. Learn More about Wan-Shan Chen's net worth.

How do I contact Wan-Shan Chen?

The corporate mailing address for Ms. Chen and other Belite Bio executives is , , . Belite Bio can also be reached via phone at 858-246-6240 and via email at [email protected]. Learn More on Wan-Shan Chen's contact information.

Has Wan-Shan Chen been buying or selling shares of Belite Bio?

During the past quarter, Wan-Shan Chen has sold $198,473.00 of Belite Bio stock. Most recently, Wan-Shan Chen sold 1,100 shares of the business's stock in a transaction on Thursday, April 9th. The shares were sold at an average price of $180.43, for a transaction totalling $198,473.00. Following the completion of the sale, the director now directly owns 9,096 shares of the company's stock, valued at $1,641,191.28. Learn More on Wan-Shan Chen's trading history.

Who are Belite Bio's active insiders?

Belite Bio's insider roster includes Wan-Shan Chen (Director), Hao-Yuan Chuang (CFO), and Nathan Mata (Chief Scientific Officer). Learn More on Belite Bio's active insiders.

Are insiders buying or selling shares of Belite Bio?

In the last year, insiders at the sold shares 5 times. They sold a total of 18,500 shares worth more than $3,323,043.00. The most recent insider tranaction occured on April, 17th when insider Nathan L Mata sold 1,000 shares worth more than $161,630.00. Insiders at Belite Bio own 13.3% of the company. Learn More about insider trades at Belite Bio.

Information on this page was last updated on 4/17/2026.

Wan-Shan Chen Insider Trading History at Belite Bio

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/9/2026Sell1,100$180.43$198,473.009,096View SEC Filing Icon  
See Full Table

Wan-Shan Chen Buying and Selling Activity at Belite Bio

This chart shows Wan-Shan Chen's buying and selling at Belite Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Belite Bio Company Overview

Belite Bio logo
Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States. The company's lead product candidate is LBS-008 (Tinlarebant), an orally administered once-a-day tablet for maintaining the health and integrity of retinal tissues in autosomal recessive Stargardt disease and geographic atrophy patients. It is also developing LBS-009, an anti-retinol binding protein 4 oral therapy that is in the preclinical development phase targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc is a subsidiary of Lin Bioscience International Ltd.
Read More

Today's Range

Now: $165.35
Low: $165.09
High: $165.09

50 Day Range

MA: $170.24
Low: $149.18
High: $190.30

2 Week Range

Now: $165.35
Low: $53.60
High: $200.00

Volume

1,549 shs

Average Volume

202,214 shs

Market Capitalization

$6.61 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A